| Issue |
Title |
| Vol 17, No 1 (2020) |
Radiofrequency renal denervation with mono-electrode and multi-electrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up |
|
|
Agaeva R.A., Danilov N.M., Shchcelkova G.V., Matchin Y.G., Chazova I.E. |
| Vol 17, No 1 (2020) |
Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2 |
|
|
Chazova I.E., Shestakova M.V., Zhernakova Y.V., Markova T.N., Mazurina N.V., Yezhov M.V., Mironova O.Y., Litvin A.Y., Elfimova E.M., Blinova N.V., Sukhareva O.Y., Ametov A.S., Akhmedzhanov N.M., Kislyak O.A., Kukharchuk V.V., Nedogoda S.V., Nebieridze D.V., Medvedev I.V., Mkrtumyan A.M., Podzolkov V.I. |
| Vol 17, No 1 (2020) |
Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population |
|
|
Ostroumova O.D., Cherniaeva M.S. |
| Vol 13, No 1 (2016) |
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension |
|
|
Valieva Z.S., Glukhova S.I., Martyniuk T.V., Chazova I.E. |
| Vol 14, No 2 (2017) |
Prevalence of hypertension in military age males according to physical evaluation results |
|
|
Melnik M.V., Uvarovskaya B.V., Makson I.P., Ivanov A.A. |
| Vol 16, No 2 (2019) |
Drug-induced arterial hypertension |
|
|
Ostroumova O.D., Kulikova M.I. |
| Vol 16, No 3 (2019) |
Experience of the management of patients with pulmonary hypertension in the Republic of Karelia |
|
|
Ryabkov V.A., Vezikova N.N., Malygin A.N., Novozhilova N.V., Merenkov V.V. |
| Vol 11, No 4 (2014) |
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension |
|
|
Valieva Z.S., Valeeva E.G., Glukhova S.I., Martynyuk T.V., Chazova I.E. |
| Vol 13, No 2 (2016) |
Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis |
|
|
Yudkina N.N., Valeeva E.G., Taran I.N., Nikolaeva E.V., Paramonov V.M., Kurmukov I.A., Valieva Z.S., Arkhipova O.A., Martynyuk T.V., Volkov A.V., Nasonov E.L., Chazova I.E. |
| Vol 14, No 4 (2017) |
Features of the use of torasemide in arterial hypertension |
|
|
Baryshnikova G.A., Chorbinskajya S.A. |
| Vol 11, No 4 (2014) |
Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system |
|
|
Mozheyko M.E., Eregin S.Y., Vigdorchik A.V., Klimovskaia I.M., Riahi F., Hughes D. |
| Vol 14, No 2 (2017) |
Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data) |
|
|
Oshchepkova E.V., Lazareva N.V., Chazova I.E. |
| Vol 15, No 4 (2018) |
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension |
|
|
Arkhipova O.A., Gratsianskaya S.E., Martynyuk T.V. |
| Vol 14, No 4 (2017) |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V |
|
|
Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Ovchinnikov A.G., Panchenko E.P., Fedotkina Y.A., Stenina M.B., Trophimova O.P., Ageev F.T. |
| Vol 10, No 2 (2013) |
Sartans in the treatment of high-risk hypertension: the abilities of candesartan |
|
|
Morozova T.E. |
| Vol 16, No 3 (2019) |
Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice |
|
|
Gratsianskaya S.E., Valieva Z.S., Zorin A.V., Martynyuk T.V. |
| Vol 15, No 2 (2018) |
Possibilities of treatment of patients with resistant arterial hypertension |
|
|
Shugushev Z.K., Maximkin D.A., Ryumina A.S. |
| Vol 11, No 4 (2014) |
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension |
|
|
Grigin V.A., Danilov N.M., Sagaydak O.V., Shelkova G.V., Chazova I.Y. |
| Vol 15, No 3 (2018) |
Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment |
|
|
Aksenova A.V., Esaulova T.E., Sivakova O.A., Chazova I.E. |
| Vol 16, No 4 (2019) |
Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension |
|
|
Karabasheva M.B., Danilov N.M., Sagaidak O.V., Matchin Y.G., Chazova I.E. |
| Vol 15, No 2 (2018) |
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment |
|
|
Arkhipova O.A., Martynyuk T.V. |
| Vol 12, No 4 (2015) |
Myocardial ischemia in patients with pulmonary arterial hypertension |
|
|
Arkhipova O.A., Martyniuk T.V., Valeeva E.G., Ryabykina G.V., Samoylenko L.E., Sergienko V.B., Chazova I.E. |
| Vol 14, No 2 (2017) |
Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine |
|
|
Kuznetsova E.G., Glukhova S.I., Martynyuk T.V., Nakonechnikov S.N., Chazova I.E. |
| Vol 13, No 3 (2016) |
Workplace hypertension": focus on emotional and personality traits in patients |
|
|
Ostroumova O.D., Pervichko E.I., Zinchenko Y.P. |
| Vol 11, No 3 (2014) |
Possibilities ARB II (sartans) in hypertensive patients |
|
|
Morozova T.E., Andrushchishina T.B., Gontarenko S.V. |
| Vol 16, No 2 (2019) |
Dynamics of ECG indicators in patients with chronic thromboembolic pulmonary hypertension after transluminal pulmonary balloon angioplasty |
|
|
Karabasheva M.B., Danilov N.M., Sagaidak O.V., Matchin I.G., Chazova I.E. |
| Vol 13, No 3 (2016) |
Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology |
|
|
Dolgova E.V., Fedorovich A.A., Martynyuk T.V., Rogoza A.N., Chazova I.E. |
| Vol 13, No 3 (2016) |
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan |
|
|
Zhernakova Y.V., Chazova I.E. |
| Vol 16, No 4 (2019) |
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy |
|
|
Oshchepkova E.V., Avalyan A.A., Rogoza A.N., Gorieva S.B., Saidova M.A., Chazova I.E. |
| Vol 16, No 2 (2019) |
Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study |
|
|
Martynyuk T.V. |
| Vol 15, No 4 (2018) |
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity |
|
|
Zheleznova E.A., Zhernakova Y.V., Chazova I.E., Rogoza A.N., Zairova A.R., Shariya M.A., Yarovaya E.B., Orlovsky A.A., Blinova N.V., Azimova M.O., Gorieva S.B., Konosova I.D. |
| Vol 14, No 3 (2017) |
Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects |
|
|
Luchinina E.V., Kompaniets O.G., Kizhvatova N.V. |
| Vol 14, No 1 (2017) |
Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study) |
|
|
Efremova Y.E., Oshchepkova E.V., Zhernakova Y.V., Chazova I.E., Iarovaia E.B., Shalnova S.A., Rotar O.P., Konradi A.O., Shliakhto E.V., Boitsov S.A. |
| Vol 13, No 1 (2016) |
The role of b-blockers in treatment of hypertension, according to Russian and European experts |
|
|
Ostroumova O.D., Fomina V.M., Shchukina G.N., Smoliarchuk E.A. |
| Vol 12, No 2 (2015) |
Ser49Gly polymorphic markers associations of ADRB1 gene and 4a/4b eNOS gene with hypertension and ischemic heart disease among the population of mountain shoria natives |
|
|
Mulerova T.A., Rubtsova E.V., Kuz'mina A.A., Tatarnikova N.P., Maksimov V.N., Voevoda M.I., Ogarkov M.I. |
| Vol 11, No 3 (2014) |
Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan |
|
|
Trukhan D.I. |
| Vol 10, No 4 (2013) |
Coagulogic risk factors of heart disease in the adult population of Tomsk |
|
|
Dobrovolsky A.B., Titaeva E.V., Yarovaya E.B., Storozhilova A.N., Zhernakova Y.V., Oschepkova E.V., Panchenko E.P., Trubacheva I.A., Serebryakova V.N., Kaveshnikova V.S., Chazova I.E., Karpov R.S. |
| Vol 9, No 4 (2012) |
The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia |
|
|
Nedogoda S.V., Ledyaeva A.A., Chumachok E.V., Tsoma V.V., Salasyuk A.S. |
| Vol 6, No 4 (2009) |
Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study) |
|
|
Chazova I.E., Ratova L.G. |
| Vol 15, No 3 (2018) |
The progression of carotid vascular remodeling risk factors in patients with arterial hypertension |
|
|
Pavlova O.S., Korobko I.Y., Nechesova T.A., Liventseva M.M., Zatoloka N.V., Kovsh E.V., Ogurtsova S.E., Mrochek A.G. |
| Vol 13, No 4 (2016) |
Radiofrequency renal arteries denervation: effectively and safely |
|
|
Grigin V.A., Danilov N.M., Matchin Y.G., Chazova I.E. |
| Vol 12, No 1 (2015) |
The association of arterial hypertension and ischemic heart disease is the main problem in modern cardiology practice |
|
|
Ostroumova O.D., Dudaev V.A., Fomina V.M. |
| Vol 11, No 3 (2014) |
The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects |
|
|
Gilyarevsky S.R. |
| Vol 11, No 1 (2014) |
Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
|
|
Trukhan D.I., Tarasova L.V. |
| Vol 10, No 2 (2013) |
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension |
|
|
Tereshchenko S.N., Zhirov I.V. |
| Vol 16, No 3 (2019) |
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus |
|
|
Zhernakova J.V., Chazova I.E., Blinova N.V. |
| Vol 6, No 1 (2009) |
The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan |
|
|
Baryshnikova G.A., Baryshnikova G.A. |
| Vol 15, No 1 (2018) |
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results |
|
|
Zhernakova Y.V., Chazova I.E., Oshchepkova E.V., Shalnova S.A., Konradi A.O., Rotar O.P., Yarovaya E.B., Shlyahto E.V., Boitsov S.A. |
| Vol 14, No 2 (2017) |
Achievement of the main goals of therapy by using of a triple fixed combination of amlodipine, indapamide and perindopril (Co-Dalneva®) in patients with arterial hypertension |
|
|
Chukaeva I.I., Spiryakina Y.G., Glibko K.V., Orlov D.A., Bayramova A.S., Logunova I.Y. |
| Vol 12, No 4 (2015) |
Clinical effects of one-year physical training program in arterial hypertension patients of working age who have suffered acute myocardial infarction (Russian randomized controlled trial) |
|
|
Aronov D.M., Bubnova M.G., Krasnitskiy V.B., Ioseliani D.G., Grinshteyn Y.I., Gulyaeva S.F., Efremushkin G.G., Lyamina N.P. |
| Vol 12, No 1 (2015) |
The rise of cardiac biomarkers due to planned PCI and 1-year prognosis in patients with stable coronary artery disease and arterial hypertension |
|
|
Mironova O.Y. |
| Vol 11, No 1 (2014) |
Practical aspects of fixed combinations in the treatment of hypertension |
|
|
Ogarkov M.Y., Baranova M.N., Skripchenko A.E. |
| Vol 9, No 4 (2012) |
Analysis of associations between genetic markers of erythrocytes of ав0, Rh, mn, P, kell blood group systems and arterial hypertension at the Altai Republic population |
|
|
Ogargov M.U., Mulerova T.A., Filimonov S.N., Luzina F.A., Onishchenko E.G. |
| Vol 16, No 3 (2019) |
Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty |
|
|
Ostroumova O.D., Cherniaeva M.S. |
| Vol 15, No 4 (2018) |
Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy |
|
|
Avalyan A.A., Oshchepkova E.V., Saidova M.A., Shitov V.N., Glazkova E.V., Stenina M.B., Chazova I.E. |
| Vol 14, No 3 (2017) |
The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations |
|
|
Ostroumova O.D., Piksina G.F., Smolyarchuk E.A., Pavleeva E.E., Bondarets O.V. |
| Vol 13, No 4 (2016) |
The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide |
|
|
Ostroumova O.D., Garelik I.A., Karavashkina E.A. |
| Vol 12, No 4 (2015) |
Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity |
|
|
Poteshkina N.G., Troshina A.A. |
| Vol 11, No 4 (2014) |
Once again about the clinical efficacy and safety of sartans |
|
|
Minina Y.S., Khadzhieva B.R. |
| Vol 11, No 2 (2014) |
The benefits of candesartan usage in the treatment of arterial hypertension |
|
|
Ostroumova O.D., Bondarets O.V., Guseva T.F. |
| Vol 10, No 4 (2013) |
Modern approaches to combined therapy of arterial hypertension |
|
|
Napalkov D.A., Zhilenko A.V. |
| Vol 9, No 4 (2012) |
Diuretics in arterial hypertension: a focus on torasemide |
|
|
Baryshnikova G.A., Stepanova I.I. |
| Vol 6, No 3 (2009) |
Dynamics of blood pressure, heart rate variability and QTc in patients with metabolic syndrome on the selective betablockerand biguanide therapy. |
|
|
Ryabykina G.V., Shishova T.A., Laptev D.N., Mychka V.B., Lyutikova L.N., Kozhemyakina E.S., Shchedrina E.V., Sobolev A.V., Chazova I.E. |
| Vol 15, No 3 (2018) |
Gender differences efficiency of various dosage regimes of antihypertensive agents by patients with arterial hypertension and coronary heart disease |
|
|
Skibitsky V.V., Gorodetskaya E.V., Kudryashov E.A., Fendrikova A.V., Skibitsky A.V. |
| Vol 14, No 2 (2017) |
The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension |
|
|
Chazova I.E., Martynyuk T.V., Accetto R., Sirenko Y., Vincelj J., JWidimsky J., Barbič-Žagar B., Arhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galjavich A.S., Rotar' O.P., Haisheva L.A., Nedogoda S.V. |
| Vol 13, No 4 (2016) |
Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension |
|
|
Shchelkova G.V., Zairova A.R., Danilov N.M., Rogoza A.N., Chazova I.E. |
| Vol 12, No 3 (2015) |
Gender differences renin-angiotensin-aldosterone system and its relation to humoral factors in patients with arterial hypertension |
|
|
Dadashova G.M. |
| Vol 11, No 4 (2014) |
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders |
|
|
Zhernakov Y.V., Chazova I.Y. |
| Vol 11, No 1 (2014) |
The telmisartan and amlodipine combination in the treatment of hypertension |
|
|
Shehyan G.G., Yalymov A.A., Schikota A.M., Zadionchenko V.S., Varentsov S.I. |
| Vol 10, No 1 (2013) |
Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus |
|
|
Barsukov A.V., Glukhovskoy D.V., Talantseva M.S., Bagaeva Z.V., Pronina E.V., Zobnina M.P., Sveklina T.S., Korovin A.E. |
| Vol 16, No 2 (2019) |
Orthostatic reactions and cognitive dysfunctions in elderly and senile patients with arterial hypertension |
|
|
Atyunina I.V., Oschepkova E.V., Rogoza A.N., Lazareva N.V. |
| Vol 6, No 3 (2009) |
Efficacy of the fixed combination β-blocker and calcium antagonist Logimax at women with an essential hypertensionin different age groups |
|
|
Ostroumova O.D., Zhukova O.V., Golovina O.V., Srednyakov A.V., Otdelenov A.V. |
| Vol 15, No 2 (2018) |
Improving blood pressure control, organoprotection and metabolic disorders correction in patients with hypertension switching from diuretic-based combinations to fixed combination lisinopril + amlodipine + rosuvastatin |
|
|
Nedogoda S.V., Chumachek E.V., Ledyaeva A.A., Tsoma V.V., Salasyuk A.S., Smirnova V.O., Khripaeva V.Y., Palashkin R.V., Popova E.A. |
| Vol 13, No 2 (2016) |
Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy |
|
|
Ostroumova O.D., Kochetkov A.I., Lopukhina M.V. |
| Vol 12, No 1 (2015) |
The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome |
|
|
Skibickiy V.V., Fendrikova A.V., Skibickiy A.V., Syrotenko D.V. |
| Vol 11, No 3 (2014) |
Pharmacoepidemiological study of recommendations of diuretics for the treatment of hypertension in the outpatient setting |
|
|
Ponomareva A.I., Kompaniets O.G., Linchak R.M., Nemirovskaya M.M., Strokan M.V., Babich A.E. |
| Vol 11, No 1 (2014) |
Aldosterone synthase gene polymorphism in patients with hypertension combined ischemic heart disease with in various left ventricular mass |
|
|
Yahontov D.A., Derisheva D.A., Gulyaeva L.F. |
| Vol 9, No 4 (2012) |
Electrical and viscoelastic parameters of erythrocytes in patients with different degrees of arterial hypertension |
|
|
Gromov A.A., Kruchinina M.V., Rabko A.V., Baum V.A., Generalov V.M. |
| Vol 16, No 1 (2019) |
Obesity and hypertension: the role of criteria |
|
|
Tsygankova D.P., Krivoshapova K.E., Maksimov S.A., Indukaeva E.V., Shapovalova E.B., Artamonova G.V., Barbarash O.L. |
| Vol 14, No 3 (2017) |
Dynamics of clinico-psychological characteristics in patients with obstructive sleep apnea syndrome and arterial hypertension after one month of the use of CPAP therapy |
|
|
Konovalova K.I., Elfimova E.M., Mikhailova O.O., Fedorova V.I., Litvin A.Y. |
| Vol 13, No 4 (2016) |
The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea |
|
|
Elfimova E.M., Zairova A.R., Andrievskaya M.V., Bogieva R.M., Rogoza A.N., Litvin A.Y. |
| Vol 12, No 4 (2015) |
Effectiveness of combined antihypertensive treatment depending on the phenomenon of salt sensitivity in patients with refractory arterial hypertension |
|
|
Skibitskiy V.V., Garkusha E.S., Fendrikova A.V. |
| Vol 12, No 2 (2015) |
Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension |
|
|
Elfimova E.M., Aksenova A.V., Litvin A.Y., Chazova I.E. |
| Vol 11, No 3 (2014) |
Why occurrence of arterial hypertension with age becomes frequent? |
|
|
Poseliugina O.B., Poseliugina E.B., Al-Galban N. |
| Vol 10, No 4 (2013) |
Rational pharmacotherapy of hypertension. Urapidil potential |
|
|
Morozova T.E., Andruschishina T.B., Shmarova D.G. |
| Vol 9, No 4 (2012) |
Diurnal blood pressure variability as a risk factor for complications of arterial hypertension |
|
|
Ostroumova O.D., Reznikova K.U. |
| Vol 6, No 4 (2009) |
Amlodipine: its ability to reduce the risk of complications of arterial hypertension |
|
|
Runikhina N.K., Tkacheva O.N. |
| Vol 15, No 2 (2018) |
Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion |
|
|
Litvin A.Y., Elfimova E.M., Chazova I.E. |
| Vol 14, No 2 (2017) |
Clinical-pharmacological priorities in the election of blockators of the renin-angiotenzine system and diuretics in patients with uncompleted hypertension |
|
|
Ponomareva A.I., Ketova G.G., Kompaniets O.G. |
| Vol 13, No 3 (2016) |
The role of bisoprolol in the management of patients with arterial hypertension |
|
|
Nedogoda S.V. |
| Vol 12, No 1 (2015) |
Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases |
|
|
Dolgusheva Y.A., Agapova O.Y., Zykov K.A., Chazova I.E. |
| Vol 11, No 3 (2014) |
Nebivolol for treatment patients with arterial hypertension |
|
|
Mikheeva O.M., Komisarenko I.A. |
| Vol 11, No 2 (2014) |
Efficacy and safety of amlodipine and perindopril (Prestance) fixed combination in patients with arterial hypertension during the summer heat |
|
|
Chazova I.E., Ageev F.T., Smirnova M.D., Ageeva N.V., Fofanova T.V., Svirida O.N., Mikhailov G.V., Levin A.M., Revich B.A. |
| Vol 10, No 2 (2013) |
Factors influencing compliance with lifestyle modification in an organized population |
|
|
Alekseeva T.S., Ogarkov M.Y., Skripchenko A.E., Yankin M.Y. |
| Vol 16, No 4 (2019) |
Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old? |
|
|
Adasheva T.V., Samorukova E.I., Zadionchenko V.S., Laricheva K.A. |
| Vol 6, No 1 (2009) |
Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin |
|
|
Ezhov M.V., Yezhov M.V. |
| Vol 15, No 1 (2018) |
Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2 |
|
|
Statsenko M.E., Turkina S.V., Titarenko M.N. |
| Vol 14, No 1 (2017) |
Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application |
|
|
Maksimov M.L., Dralova O.V. |
| Vol 12, No 1 (2015) |
The role of beta-blockers in the treatment of arterial hypertension: what do we know today |
|
|
Zhernakova Y.V., Chazova I.E. |
| Vol 11, No 3 (2014) |
The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’) |
|
|
Ostroumova O.D., Guseva T.F., Bondarets O.V. |
| 1 - 100 of 287 Items |
1 2 3 > >> |
